Community-based Neuroendocrine Tumor (NET) Research Study

Completed

Conditions studied: Gastroenteropancreatic Neuroendocrine Tumors

In brief

The purpose of this trial is to assess time to disease progression of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors treated with Lanreotide Depot. This is an observational study therefore all data collected will be in accordance with the routine practice of physicians.

Key facts

Study ID

NCT02730104

Run by

Ipsen

People needed

100

Starts

2015-11-23

Expected to finish

2020-05-13

Last updated by the study team

2020-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed locally advanced or metastatic, well-differentiated neuroendocrine tumor (NET) of the small bowel, stomach, colon/rectum, or pancreas (low or intermediate grade; i.e. G1 or G2)
• Treatment with lanreotide depot (Somatostatin Analogue-naïve patients and patients with prior treatment with octreotide long-acting repeatable (LAR) are permitted)
• Radiographically measurable disease
• Has signed the most recent written Patient Informed Consent Form

You may not qualify if…

• Known hypersensitivity to lanreotide
• Poorly differentiated or high grade carcinoma, or patients with neuroendocrine tumors not of lung or thymic origin
• Patients who have previously initiated treatment with lanreotide depot prior to the start of the study cannot have progressed between lanreotide initiation and study entry
• Significant history of uncontrolled cardiac disease (ie, myocardial infarction within 6 months prior to enrollment or has congestive heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia or active conduction system abnormalities)

Where it is running

• Arizona Oncology Associates — Sedona, Arizona, United States
• Rocky Mountain Cancer Centers — Denver, Colorado, United States
• Illinois Cancer Specialists — Arlington Heights, Illinois, United States
• Oncology Hematology Care, Inc. — Cincinnati, Ohio, United States
• Texas Oncology - Beaumont, Mamie McFaddin Ward Cancer Center — Beaumont, Texas, United States
• Texas Oncology - Dallas Presbyterian Hospital — Dallas, Texas, United States
• Texas Oncology - Baylor Charles A. Sammons Cancer Center — Dallas, Texas, United States
• Texas Oncology - Denton South — Denton, Texas, United States
• Texas Oncology — Houston, Texas, United States
• Texas Oncology-Tyler — Tyler, Texas, United States
• Texas Oncology - Deke Slayton Cancer Center — Webster, Texas, United States
• Yakima Valley Memorial Hospital/North Star Lodge — Yakima, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.